It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
Lets dive in
The Dosage Clinical trials used various doses, with the 12 mg dose providing the biggest impact
Qsymia vs Wegovy or Qsymia vs Zepbound outlines significant distinctions
doi: 10.7759/cureus.45487 92 VergsBAboyansVAngoulvantDBoutouyriePCariouBHyafilFet al
Call (954) 551-3508 1911 Harrison Street, Hollywood, FL 33020 Retatrutide Peptide Overview: Doses, Potential Benefits, Side Effects, Prescription By Dr
